Passage Bio, Inc.
PASG
$7.35
-$0.29-3.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.98M | -7.75M | -9.39M | -15.41M | -12.73M |
| Total Depreciation and Amortization | 177.00K | 181.00K | 169.00K | 201.00K | 719.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.12M | 611.00K | 937.00K | 3.62M | 882.00K |
| Change in Net Operating Assets | 2.21M | 2.10M | 1.95M | -2.27M | 2.68M |
| Cash from Operations | -6.48M | -4.85M | -6.33M | -13.85M | -8.44M |
| Capital Expenditure | -- | -- | -- | -- | -14.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 585.00K | 585.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 39.05M | 13.69M |
| Cash from Investing | 0.00 | 0.00 | 585.00K | 39.63M | 13.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.00K | 0.00 | 14.00K | -- | 47.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.00K | 0.00 | 14.00K | -- | 47.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.47M | -4.85M | -5.73M | 25.78M | 5.28M |